RE: IMO...16 Jul 2025 14:04
the answer is obviously long. abridged ai response:
"
bottom line (bullish): with only ~5 events in the first two years, the vaccine + ipi-nivo combo is exhibiting durable disease control; the heavy censoring is simply the flip-side of durable benefit, not a flaw in the analysis.
bottom line (bearish): with so few events and such heavy censoring, today’s curve may over-state efficacy; once follow-up matures and more real progressions occur, the benefit could shrink toward historical benchmarks.
likely reality
both readings contain truth. the data do look promising—durable disease control with a low event count is what you hope to see in an early cancer-vaccine trial. but the statistical footing is still fragile: the confidence interval around every point on the curve is wide, and the curve can change shape dramatically with each new scan cycle. the next milestones are:
week-25 orr and pfs for the full 43-patient cohort (promised for h1 2025)
updated km curve once ~13–15 events occur, giving the first calculable median pfs
those read-outs will tell us whether today’s bullish story withstands the maturing data—or whether the bearish concerns prove prescient.
"
it also mentions you being wrong previously:
"
everything visible on slide 11 — censor ticks, explanatory caption, step-wise curve, absence of a median — is exactly what one expects from a ******-meier analysis. the critic’s specific allegation that the company “calculated mpfs arithmetically” is therefore almost certainly wrong, even though their broader warnings about small-sample uncertainty and heavy censoring remain valid.
"
it also mentioned this:
"
censor pattern is predictable regular tick spacing matches scheduled imaging visits; that is what you expect when patients remain on study, reinforcing the view that censoring is administrative rather than due to losses or toxicity.
"
scinv, i can assure you that i surrender to truth, i am open to being wrong about just about anything in life. but what i see here is you hastily misjudging my statements and assuming i trade fx when i don't. you (likely) misjudging scancell's analysis of the data (km curve vs arithmetic derived estimate). you having issues with interpersonal skills, ego, and having a grudge against scancell because you perceive that they deceived you intentionally. none of that means you must be wrong about everything but i think the truth is more likely that you just don't know and you're hanging around here to buy back in to the company you have a grudge against (and tell everyone you were right to wait for hard data) or if things go badly, gloat that you knew everyone was wrong (even though you admitted you might buy back in on promising results despite simultaneously claiming you were lied to).